{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:16:21Z","timestamp":1785860181501,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ECS00000017"],"award-info":[{"award-number":["ECS00000017"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["T4-AN-07"],"award-info":[{"award-number":["T4-AN-07"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["POS 2014-2020"],"award-info":[{"award-number":["POS 2014-2020"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["I53C22001300001"],"award-info":[{"award-number":["I53C22001300001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Government of Italy Ministry of Education University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijantimicag.2025.107571","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:37:15Z","timestamp":1751564235000},"page":"107571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-7094","authenticated-orcid":false,"given":"Novella","family":"Cesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5478-8223","authenticated-orcid":false,"given":"Alessandro","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Materazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9199-3340","authenticated-orcid":false,"given":"Cartesio","family":"D\u2019Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Iannetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Tavanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-034X","authenticated-orcid":false,"given":"Mariagrazia","family":"Di Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107571_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0004-2012","article-title":"Bacterial prostatitis: bacterial virulence, clinical outcomes, and new directions","volume":"4","author":"Krieger","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0002","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0003","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s10096-012-1680-0","article-title":"Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens","volume":"31","author":"Cunha","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0004","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12223-009-0064-z","article-title":"Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis \u2013 Case report","volume":"54","author":"Letkiewicz","year":"2009","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0005","article-title":"Phage-antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency","volume":"11","author":"Liu","year":"2022","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0006","unstructured":"EUCAST: MIC determination; n.d. https:\/\/www.eucast.org\/ast_of_bacteria\/mic_determination [accessed October 18, 2024]."},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0007","unstructured":"EUCAST: Rationale Documents; n.d. https:\/\/www.eucast.org\/publications-and-documents\/rd [accessed August 16, 2024]."},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0008","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijantimicag.2018.09.006","article-title":"Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus","volume":"52","author":"Tkhilaishvili","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu Liu","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2019.00332","article-title":"Isothermal microcalorimetry detects the presence of persister cells in a Staphylococcus aureus biofilm after vancomycin treatment","volume":"10","author":"Butini","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0011","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgar.2024.01.021","article-title":"Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa","volume":"37","author":"Ferretti","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01434","article-title":"Phage therapy in prostatitis: recent prospects","volume":"9","author":"G\u00f3rski","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1243824","article-title":"Case report: successful treatment of recurrent E. coli infection with bacteriophage therapy for patient suffering from chronic bacterial prostatitis","volume":"14","author":"Johri","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0014","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3389\/fmicb.2018.01832","article-title":"Adapted bacteriophages for treating urinary tract infections","volume":"9","author":"Ujmajuridze","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology Guidelines on Urological Infections: summary of the 2024 Guidelines","volume":"86","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0016","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1592\/phco.30.11.1136","article-title":"Vancomycin-resistant enterococcal urinary tract infections","volume":"30","author":"Heintz","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0017","doi-asserted-by":"crossref","first-page":"s40","DOI":"10.1093\/infdis\/131.Supplement.S40","article-title":"Effectiveness of achievable urinary concentrations of tetracyclines against \u201ctetracycline-resistant\u201d pathogenic bacteria","volume":"131","author":"Musher","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0018","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-5347(17)55594-9","article-title":"Comparison of 4 and 10 days of doxycycline treatment for urinary tract infection","volume":"124","author":"Lockey","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0019","first-page":"95","article-title":"Lymecycline or doxycycline for treatment of urinary-tract infections: a comparison of attained urine concentrations","volume":"20","author":"Ericsson","year":"1978","journal-title":"Microbios"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0897190016642362","article-title":"Successful doxycycline therapy in a patient with Escherichia coli and multidrug-resistant Klebsiella pneumoniae urinary tract infection","volume":"30","author":"White","year":"2017","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/srep31964","article-title":"The role of doxycycline in the therapy of multidrug-resistant E. coli \u2013 an in vitro study","volume":"6","author":"Lai","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijantimicag.2014.12.019","article-title":"Persistent extended-spectrum \u03b2-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline","volume":"45","author":"Cunha","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000455610","article-title":"Doxycycline levels in prostatic tissue and blood","volume":"1","author":"Mathisen","year":"1975","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0024","doi-asserted-by":"crossref","first-page":"ofad051","DOI":"10.1093\/ofid\/ofad051","article-title":"Application of phage therapy in a case of a chronic hip-prosthetic joint infection due to Pseudomonas aeruginosa : an Italian real-life experience and in vitro analysis","volume":"10","author":"Cesta","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00924-19","article-title":"Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa","volume":"64","author":"Tkhilaishvili","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198274","article-title":"Isolation and characterization of a novel Escherichia coli kayfunavirus phage DY1","volume":"293","author":"Yuan","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0027","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41429-019-0149-0","article-title":"Doxycycline inhibits pre-rRNA processing and mature rRNA formation in E. coli","volume":"72","author":"Chukwudi","year":"2019","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2025.107571_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9010152","article-title":"Aztreonam lysine increases the activity of phages E79 and phiKZ against Pseudomonas aeruginosa PA01","volume":"9","author":"Davis","year":"2021","journal-title":"Microorganisms"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:50:22Z","timestamp":1758124222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0924857925001268"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107571","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107571"}}